（文章来源：证券日报） 证券日报网讯 8月18日晚间，海正生材发布公告称，公司拟将回购股份价格上限由12元/股（含）调整 为17元/股（含），并同时对回购实施期限延长6个月，延长至2026年2月27日止，即回购实施期限为自 2024年8月28日至2026年2月27日。 ...

（文章来源：证券日报） 证券日报网讯 8月18日晚间，海正生材发布公告称，公司第七届董事会第十七次会议审议通过了《2025 年半年度报告及摘要》等多项议案。 ...

一、复牌 1、中国船舶：已刊登异议股东收购请求权申报结果，股票复牌。 二、并购、定增 1、爱柯迪：拟发行股份及支付现金购买卓尔博71%股权。 2、引力传媒：拟定增募资不超过4.7亿元，用于全球社交营销云项目、内容创意云项目、补充流动资 金。 三、回购 1、山东玻纤：将股份回购价格上限由5.41元/股调整为10.22元/股。 2、二连板新天药业：正在筹划对参股公司汇伦医药追加股权投资。 3、特变电工：拟发行可转债募资不超过80亿元，用于准东20亿Nm3/年煤制天然气项目。 4、久吾高科：拟发行可转债募资不超过5.04亿元，用于班戈错盐湖年产2000吨氯化锂中试生产线BOT 项目、特种无机膜组件及装置生产线项目、补充流动资金。 5、蔚蓝锂芯：控股子公司淮安光电在马来西亚进行LED项目建设投资，项目总投资8388万美元，新建 LED CSP项目；项目全部建成达产后，预计将形成700KK芯片点测分选及CSP芯片封装月产能。 2、海正生材：拟将回购股份价格上限由12元/股（含）调整为17元/股（含），并同时对回购实施期限 延长6个月，延长至2026年2月27日止。 四、对外投资 1、景嘉微：拟2.2亿元增资诚恒微成为其 ...

人民财讯8月18日电，海正生材(688203)8月18日晚间披露2025年半年报，公司上半年实现营业收入4.08 亿元，同比下降5.28%；归母净利润为318.15万元，同比下降87.32%。基本每股收益0.02元。报告期 内，产品售价同比下降，利润收窄，利息收入和政府补助同比减少。 ...

Core Viewpoint - The report highlights the financial performance and operational status of Zhejiang Hisun Biomaterials Co., Ltd. for the first half of 2025, indicating a significant decline in profits due to reduced product prices and lower government subsidies, despite a slight increase in sales volume of polylactic acid (PLA) resin [2][13]. Company Overview and Financial Indicators - Zhejiang Hisun Biomaterials Co., Ltd. specializes in the research, production, and sales of polylactic acid, a biodegradable and bio-based polymer material [3][7]. - The company reported a revenue of 408.21 million yuan, a decrease of 5.28% compared to the same period last year [6][13]. - The total profit for the period was 9.38 million yuan, down 69.14% year-on-year, while the net profit attributable to shareholders was 3.18 million yuan, reflecting an 87.32% decline [6][13]. - The company’s net assets were reported at 1.48 billion yuan, a slight decrease of 0.95% from the previous year [6]. Industry and Main Business Situation - The company operates within the chemical fiber manufacturing industry, focusing on the production of PLA, which is derived from renewable biomass resources [4][7]. - PLA is recognized for its environmental benefits, aligning with carbon neutrality policies and offering a sustainable alternative to traditional plastics [4][5]. - The company has developed a complete industrial chain for PLA, mastering key technologies for its production and modification [7][15]. Market Position and Competitive Advantage - The company is the first in China and the second globally to commercialize PLA production, maintaining a leading market share domestically [12][13]. - It has established a strong brand reputation and product quality, achieving certifications such as FDA compliance and EU REACH registration, which enhance its marketability [17]. - The company has a robust R&D framework, continuously innovating and expanding its product offerings to meet market demands [15][16]. Operational Highlights - The company produced 24,100 tons of pure PLA resin in the first half of 2025, with a production capacity utilization rate exceeding 80% [14]. - Despite challenges in export markets due to international trade policies, the company managed to maintain stable sales volumes, particularly in the extrusion and thermoforming sectors [13][14]. - The company’s R&D investment increased by 7.35% year-on-year, indicating a commitment to innovation and product development [15].

浙江海正生物材料股份有限公司2025 年半年度报告摘要 公司代码：688203 公司简称：海正生材 浙江海正生物材料股份有限公司 浙江海正生物材料股份有限公司2025 年半年度报告摘要 第一节 重要提示 规划，投资者应当到 www.sse.com.cn 网站仔细阅读半年度报告全文。 公司已在本报告中详细阐述公司在经营过程中可能面临的各种风险及应对措施，敬请查阅本报告 "第三节 管理层讨论与分析"之"四、风险因素"中相关内容。 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 不适用 □适用 √不适用 第二节 公司基本情况 公司股票简况 公司股票简况 股票种类 股票上市交易所 股票简称 股票代码 变更前股票简称 上海证券交易所科 A股 海正生材 688203 不适用 创板 公司存托凭证简况 □适用 √不适用 联系人和联系方式 联系人和联系方式 董事会秘书（信息披露境内代 证券事务代表 表） 姓名 张敏 卢秀剑 电话 0576-88931556 0576-88931556 浙江海正生物材料股份有限公司2025 年半年度报告摘要 办公地址 浙江省台州市台州湾新区台州 浙江省台州市台州 湾新区台州 湾大道 ...

Core Viewpoint - The board of directors of Zhejiang Haizheng Biological Materials Co., Ltd. held its 17th meeting of the 7th session, where several key resolutions were passed, including the approval of the 2025 semi-annual report and adjustments to the share repurchase plan [1][2][3] Group 1: Semi-Annual Report - The board approved the 2025 semi-annual report and its summary, which was reviewed by the audit committee [1] - The voting results for this resolution were unanimous, with 9 votes in favor and no opposition or abstentions [1] Group 2: Fund Usage Report - The board approved a special report on the storage and usage of funds raised in the first half of the year [2] - This resolution also received unanimous support, with 9 votes in favor [2] Group 3: Quality Improvement Action Plan - The board approved a semi-annual evaluation report on the quality improvement and efficiency enhancement action plan for 2025 [2] - The voting results were again unanimous, with 9 votes in favor [2] Group 4: Election of Executive Director - The board elected Chairman Zheng Baichao as the representative director to execute company affairs, confirming no change in the legal representative of the company [2][3] - This resolution was passed with unanimous support, receiving 9 votes in favor [3] Group 5: Audit Committee Confirmation - The board confirmed the members and convener of the audit committee, which includes professionals with accounting expertise [3] - The voting results were unanimous, with 9 votes in favor [3] Group 6: Share Repurchase Plan Adjustment - The board approved an adjustment to the maximum repurchase price from 12 CNY per share to 17 CNY per share and extended the implementation period by 6 months, now ending on February 27, 2026 [3] - This resolution also received unanimous support, with 9 votes in favor [3]

Core Viewpoint - Zhejiang Haizheng Biomaterials Co., Ltd. has announced an adjustment to its share repurchase plan, increasing the maximum repurchase price from 12 RMB per share to 17 RMB per share and extending the implementation period by 6 months until February 27, 2026 [1][3]. Summary by Sections 1. Basic Information on Share Repurchase - The company plans to repurchase its issued A-shares using its own funds through the Shanghai Stock Exchange, initially set at a maximum price of 12 RMB per share and a total repurchase fund between 20 million RMB and 30 million RMB [1][2]. 2. Progress of Share Repurchase - As of the disclosure date, the company has repurchased a total of 1,482,364 shares, accounting for approximately 0.73% of the total share capital of 202,678,068 shares, with a total expenditure of approximately 14.29 million RMB [3]. 3. Reasons for Adjusting the Repurchase Plan - The adjustment to the repurchase price and extension of the implementation period are due to the recent increase in the company's stock price, which exceeded the previously set maximum repurchase price. This change aims to ensure the smooth execution of the repurchase plan and protect shareholder interests [3][4]. 4. Rationality and Necessity of the Adjustment - The adjustment complies with relevant regulations and is based on market conditions and the progress of the repurchase. The new maximum price is set at 150% of the average trading price over the last 30 trading days prior to the board's decision [3][4]. 5. Decision-Making Process for the Adjustment - The adjustment was approved by the company's seventh board of directors' seventeenth meeting, with all directors present. This matter does not require submission to the shareholders' meeting for approval [5].

Core Viewpoint - Haizheng Shengcai (688203.SH) reported a decline in both revenue and net profit for the first half of 2025, indicating financial challenges faced by the company [1] Financial Performance - The company's operating revenue for the first half of 2025 was 408 million yuan, a year-on-year decrease of 5.28% [1] - The net profit attributable to shareholders of the listed company was 3.1815 million yuan, representing a significant year-on-year decline of 87.32% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 2.3461 million yuan, down 88.82% year-on-year [1] - Basic earnings per share were reported at 0.02 yuan [1]

（文章来源：每日经济新闻） 海正生材8月18日晚间发布公告称，公司第七届第十七次董事会会议于2025年8月18日在公司会议室以现 场加通讯方式召开。会议审议了《2025年半年度报告及摘要》等文件。 ...